Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.

Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.

Cancer Res. 2010 Jun 15;70(12):5184-93. doi: 10.1158/0008-5472.CAN-10-0145. Epub 2010 May 25.

2.

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.

Cancer Res. 2009 Jul 15;69(14):5761-7. doi: 10.1158/0008-5472.CAN-08-4797. Epub 2009 Jul 7.

3.

MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.

FEBS J. 2009 Jun;276(11):2966-82. doi: 10.1111/j.1742-4658.2009.07014.x. Epub 2009 Apr 16.

4.

MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).

Wu D, Huang HJ, He CN, Wang KY.

Int J Gynecol Cancer. 2013 Sep;23(7):1191-7. doi: 10.1097/IGC.0b013e31829ea779.

PMID:
23851675
5.

MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2).

Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, Choi YC.

J Biol Chem. 2008 Jun 27;283(26):18158-66. doi: 10.1074/jbc.M800186200. Epub 2008 May 2.

6.

miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.

Henry JC, Park JK, Jiang J, Kim JH, Nagorney DM, Roberts LR, Banerjee S, Schmittgen TD.

Biochem Biophys Res Commun. 2010 Dec 3;403(1):120-5. doi: 10.1016/j.bbrc.2010.10.130. Epub 2010 Nov 3.

7.

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.

Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, Jeng YM.

Carcinogenesis. 2010 Sep;31(9):1516-22. doi: 10.1093/carcin/bgq107. Epub 2010 Jun 4.

PMID:
20525879
8.

Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.

Chen F, Zhu HH, Zhou LF, Wu SS, Wang J, Chen Z.

Oncol Rep. 2010 May;23(5):1457-62.

PMID:
20372864
9.

The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.

Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG.

Int J Biochem Cell Biol. 2012 Dec;44(12):2321-32. doi: 10.1016/j.biocel.2012.08.006. Epub 2012 Aug 10.

PMID:
22903020
10.

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M.

Oncogene. 2008 Sep 25;27(43):5651-61. doi: 10.1038/onc.2008.178. Epub 2008 Jun 2.

PMID:
18521080
11.

Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.

Kim JH, Badawi M, Park JK, Jiang J, Mo X, Roberts LR, Schmittgen TD.

Int J Oncol. 2016 Nov;49(5):2037-2045. doi: 10.3892/ijo.2016.3677. Epub 2016 Sep 2.

PMID:
27599545
12.

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z, Liu J, Cui Y, Bian X, Bie P, Qian C.

Cancer Lett. 2011 Nov 28;310(2):160-9. doi: 10.1016/j.canlet.2011.06.027. Epub 2011 Jul 2.

PMID:
21802841
13.

Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.

Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ.

Cell Biochem Biophys. 2012 Jan;62(1):237-44. doi: 10.1007/s12013-011-9263-8.

PMID:
21847633
14.

MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.

Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L, Tian Q, Zha R, Zhan R, He X.

Carcinogenesis. 2011 Nov;32(11):1641-7. doi: 10.1093/carcin/bgr199. Epub 2011 Sep 1.

PMID:
21890460
15.

MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.

Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan C, Liu S, Zhang Y.

PLoS One. 2014 Dec 22;9(12):e115565. doi: 10.1371/journal.pone.0115565. eCollection 2014.

16.

MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells.

Wu L, Cai C, Wang X, Liu M, Li X, Tang H.

FEBS Lett. 2011 May 6;585(9):1322-30. doi: 10.1016/j.febslet.2011.03.067. Epub 2011 Apr 7.

17.

MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.

Sakurai K, Furukawa C, Haraguchi T, Inada K, Shiogama K, Tagawa T, Fujita S, Ueno Y, Ogata A, Ito M, Tsutsumi Y, Iba H.

Cancer Res. 2011 Mar 1;71(5):1680-9. doi: 10.1158/0008-5472.CAN-10-2345. Epub 2010 Dec 28.

18.

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.

Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X.

Cancer Lett. 2009 Mar 8;275(1):44-53. doi: 10.1016/j.canlet.2008.09.035. Epub 2008 Nov 8.

PMID:
19006648
19.

Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma.

Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang SM, Zheng L, Liang A, Tao W, Cao X.

Cancer Cell. 2011 Feb 15;19(2):232-43. doi: 10.1016/j.ccr.2011.01.001.

Supplemental Content

Support Center